Carol Webb - Dec 12, 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Stock symbol
CTOR
Transactions as of
Dec 12, 2024
Transactions value $
$0
Form type
4
Date filed
12/16/2024, 04:07 PM
Previous filing
Nov 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +125K $0.00 125K Dec 12, 2024 Common Stock 125K $1.07 Direct F1
holding CTOR Stock Option (Right to Buy) 150K Dec 12, 2024 Common Stock 150K $2.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2 These options are 100% vested.